Capuramcyin analogs (University of Tennessee)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCapuramcyin analogs (University of Tennessee)
Drug Alias NameMraY Inhibitors (University of Tennessee)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhospho-N-acetylmuramoyl pentapeptide transferase inhibitors
TargetsPhospho-N-acetylmuramoyl pentapeptide transferase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Tennessee Research Foundation Office of Technology TransferThe University Of Tennessee
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A